The Phase 3 data presented at AAD include a comprehensive review of the THRIVE-AA2 results and further elaborate the topline data reported in August 2022
The objective of launching these products at AAHAR is to create awareness on the consumption of protein based products
The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform
Expands robotics to 20+ specialities
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
The facility has been set up to manufacture tuberculosis testing cartridges
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Proposed combination enhances Pfizer’s position as a leading company in oncology
Marksans' OTC Famotidine Tablets USP are acid reducers
Time to combine innovation, access and technology to deliver positive patient outcomes
Subscribe To Our Newsletter & Stay Updated
